Physicians
James H. Doroshow, M.D., is the Deputy Director for Clinical and Translational Research of the National Cancer Institute and the Director of NCI’s Division of Cancer Treatment and Diagnosis. He is the author of over 400 full-length publications in the areas of molecular pharmacology, the role of oxidant stress in tumor cell signal transduction, and novel therapeutic approaches to solid tumors; he is also the Associate Editor for Oncology of the 25th Edition of the Cecil Textbook of Medicine. Following an Internal Medicine residency at the Massachusetts General Hospital, he completed a fellowship in Medical Oncology at the Medicine and Clinical Pharmacology Branches of the National Cancer Institute, NIH. Read full bio.
Alice Chen, M.D., is Senior Scientific Officer, and Head of the DTC. Her wide-ranging clinical experience includes over 25 years as a clinical investigator of many early phase clinical trials, including the first ever phase 0 trial performed under an exploratory initiative with the United States Food and Drug Administration (FDA) as well as "first-in-human" phase 1 clinical trials. Read full bio.
Sarah Shin, M.D., M.P.H., joined the Developmental Therapeutics Clinic (DTC) as a Staff Clinician after completing the Advanced Developmental Therapeutics Training Program in June 2023. She received her medical degree and MPH from the University of Miami. She completed her residency in internal medicine at the University at Buffalo and her fellowship in hematology and medical oncology at Roswell Park Comprehensive Cancer Center and the University at Buffalo.
Jibran Ahmed, M.D., is an Assistant Research Physician specializing in medical oncology with a focus on translational and clinical research in immunotherapy and genomics. He has experience in leading investigator-initiated clinical trials, and his work has contributed to advancing biomarker-driven treatment strategies. In addition to a strong background in molecular oncology, Dr. Ahmed has published widely in high-impact journals and presented at major national meetings. He is board-certified in internal medicine, adult hematology, and medical oncology. He is committed to integrating clinical expertise with genomic and immunologic insights to develop innovative therapeutic approaches for patients with cancer.
Nurse Practitioners
Jessica Mukherjee, M.S., C.R.N.P., is a Nurse Practitioner in the Developmental Therapeutics Clinic. She received her B.S. in Biology from the University of Virginia and her B.S.N. in Nursing and M.S. in Adult-Gerontology Primary Care Nurse Practitioner from Columbia University. Prior to joining DTC, she worked as a nurse practitioner in outpatient medical oncology. She is a member of the Sigma Theta Tau International Honor Society of Nursing.
Juwara Lamin is a Nurse Practitioner on the Developmental Therapeutics Team. Lamin received his Doctor of Nursing Practice degree at George Washington University and his Nurse Practitioner certification at the University of Maryland. Lamin has been at the NIH since 2001.
Ning Ma, M.S., C.R.N.P., is a Nurse Practitioner in the Developmental Therapeutics Clinic. She earned her Bachelor’s degree in nursing from Peking Union Medical College and her M.S. in Family Nurse Practitioner from the University of Maryland. Ning has been working as an oncology nurse practitioner since 2013 and joined the Developmental Therapeutics Clinic team in 2020.
Research Nurses
Nancy Moore, R.N., M.S.N., is a Clinical Research Nurse on the Developmental Therapeutics Team. She received her Bachelor’s degree from Villanova University, PA and her graduate degree from Adelphi University in Long Island NY. She has been practicing in the area of clinical research trials for more than 20 years.
Jennifer Zlott, R.N., O.C.N., joined the Developmental Therapeutics Clinic (DTC) as a Clinical Research Nurse in 2014. She received her bachelor’s degree in nursing from Madonna University in Livonia, Michigan. Prior to joining DTC, Jennifer’s experience includes working with intermediate care cardiac patients. As an oncology certified nurse, she also worked with hematopoietic stem cell transplant, hematology and oncology patients
Murielle Hogu, R.N., M.S.N., received her B.S. from Post University and her master’s degree in nursing from Walden University. Murielle has been an oncology nurse in the inpatient setting since 2010 and joined the Developmental Therapeutics Team in 2018.
Brooke Augustine, R.N., B.S.N., received her bachelor’s degree in nursing from Stevenson University in Maryland. Brooke has been an oncology nurse in the inpatient setting since 2014 and a research nurse since 2017 with a focus on phase I clinical trials.
Emma O'Neill, R.N., B.S.N., O.C.N., received her bachelor’s degree in nursing from West Chester University. Emma has been an oncology nurse in the inpatient setting since 2020 and joined the Developmental Therapeutics Clinic in 2024
Referral Coordinators
Theodore Crowder has been at the NIH for 13 years. He worked for more than 10 years on one of the in-patient units as a Program Support Assistant and won several awards in customer service. In November 2017, he joined the Early-Phase Developmental Therapeutics team at NCI.
Tanaya Allen joined the Early Phase Developmental Therapeutics team at NCI in May 2019. She has worked at NIH for 11 years as a Research Support Assistant on one of the busiest inpatient units in the hospital. Tanaya has won several awards, including those that recognize her continuous outstanding work in customer service.